Abiomed's Impella controller field action escalated to FDA's top recall tier

The US Food and Drug Administration has placed Abiomed's removal of certain Automated Impella Controllers in its highest-risk recall category, the most serious of its three tiers. The classification was entered on 6 November and published on 9 November 2026. It follows an early alert on 23 September. The agency says the affected products and the recommended actions have not changed. No financial impact has been disclosed, and the information available does not say how many consoles are involved or what the servicing programme will cost.

The commercial point that can be drawn from the notice is operational. Hospitals are not being told to take the consoles out of service. They may keep their inventory in use so that patient care is not interrupted, while Abiomed's service team arranges collection, updating and return of each unit. The affected controllers are limited to those with specific serial numbers, found on a label on the right side of the device, across three packaged configurations: product numbers 0042-0000-US, 0042-0010-US and 0042-0040-US.

Abiomed says a retrospective review of servicing records showed that some controllers need hardware, firmware or software updates. The issues it lists are a possible failure to recognise the purge cassette during setup or change, a sticky, unreliable button that could prevent menu selection and risk loss of console control, and an instability that could stop the device starting up. It also cites other software defects. Without the fixes, patients could face delayed treatment or inadequate or lost circulatory support. The updates already exist but have not reached every potentially affected unit.

Abiomed wrote to affected customers on 18 September 2026. As of 8 September, it had received no reports of serious injuries or deaths linked to the problem. The controller is the main interface for Impella catheters, running the catheter and monitoring it for alarms. US customers with questions, adverse events or an unreadable serial label can reach the Abiomed Field Service Team on 1-800-422-8666 (option 3) or at ra-abm-fieldaction@its.jnj.com. Events can also be reported to MedWatch.